Literature DB >> 4860708

(--)-Hyoscine and cyclizine as motion sickness remedies.

J J Brand, W P Colquhoun, A H Gould, W L Perry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4860708      PMCID： PMC1557305          DOI： 10.1111/j.1476-5381.1967.tb02152.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  5 in total

1.  Effects of hyoscine and meciozine on vigilance and short-term memory.

Authors:  W P COLQUHOUN
Journal:  Br J Ind Med       Date:  1962-10

2.  Effect of drugs on motion sickness produced by short exposures to artificial waves.

Authors:  E M GLASER; R A McCANCE
Journal:  Lancet       Date:  1959-04-25       Impact factor: 79.321

3.  Comparison of drowsiness induced by bonamine and marezine.

Authors:  L G LEDERER; L E PUTNAM
Journal:  J Aviat Med       Date:  1958-12

4.  Further experiments on the prevention of motion sickness.

Authors:  E M GLASER; G R HERVEY
Journal:  Lancet       Date:  1952-03-08       Impact factor: 79.321

5.  Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods.

Authors:  J J Brand; W L Perry
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468
  5 in total
  10 in total

Review 1.  The Neurophysiology and Treatment of Motion Sickness.

Authors:  Andreas Koch; Ingolf Cascorbi; Martin Westhofen; Manuel Dafotakis; Sebastian Klapa; Johann Peter Kuhtz-Buschbeck
Journal:  Dtsch Arztebl Int       Date:  2018-10-12       Impact factor: 5.594

Review 2.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 3.  Scopolamine (hyoscine) for preventing and treating motion sickness.

Authors:  Anneliese Spinks; Jason Wasiak
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

4.  Effects of caffeine and cyclizine alone and in combination on human performance, subjective effects and EEG activity.

Authors:  M Clubley; C E Bye; T A Henson; A W Peck; C J Riddington
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

5.  The time course of action of (-)-hyoscine after intramuscular injection.

Authors:  J J Brand
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

Review 6.  Antihistamines for motion sickness.

Authors:  Nadine Karrim; Ryan Byrne; Nombulelo Magula; Yougan Saman
Journal:  Cochrane Database Syst Rev       Date:  2022-10-17

7.  A comparison of triprolidine and cyclizine on histamine (H1) antagonism, subjective effects and performance tests in man.

Authors:  M Hamilton; M Bush; C Bye; A W Peck
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

8.  The attenuation of a specific cue-to-consequence association by antiemetic agents.

Authors:  J D Coil; W G Hankins; D J Jenden; J Garcia
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

Review 9.  Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

10.  Combined Administration of Melissa officinalis and Boswellia serrata Extracts in an Animal Model of Memory.

Authors:  Mohaddese Mahboubi; Mohsen Taghizadeh; Sayyed Alireza Talaei; Sayyed Mehdi Takht Firozeh; Ali Akbar Rashidi; Omid Reza Tamtaji
Journal:  Iran J Psychiatry Behav Sci       Date:  2016-08-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.